Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Bioventus Inc. (BVS : NSDQ)

• Company Description    Bioventus Inc. delivers clinically proven, cost-effective products which help people heal quickly and safely. It includes offerings for osteoarthritis, surgical and non-surgical bone healing. Bioventus Inc. is based in DURHAM, N.C. Number of Employees: 930

• Price / Volume Information    Yesterday's Closing Price: $9.28 Daily Weekly Monthly 20 Day Moving Average: 526,848 shares Shares Outstanding: 83.54 (millions) Market Capitalization: $775.20 (millions) Beta: 0.72 52 Week High: $11.25 52 Week Low: $5.81 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -4.43% -9.10% 12 Week 4.74% -3.17% Year To Date 24.73% 17.33%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 4721 EMPEROR BOULEVARD SUITE 100 - DURHAM,NC 27703 USA ph: 919-474-6700 fax: - investor.relations@bioventus.com http://www.bioventus.com

• General Corporate Information    Officers Robert E. Claypoole - President; Chief Executive Officer and Director William A. Hawkins III - Chairman Mark L. Singleton - Senior Vice President and Chief Financial Officer Ajay Dhankhar - Director Mary Kay Ladone - Director Peer Information Bioventus Inc. (GSAC) Bioventus Inc. (CASIF) Bioventus Inc. (ALCD.) Bioventus Inc. (OMNN) Bioventus Inc. (CGPI.) Bioventus Inc. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 09075A108 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/05/26 Share - Related Items Shares Outstanding: 83.54 Most Recent Split Date: (:1) Beta: 0.72 Market Capitalization: $775.20 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.22 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.79 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: 10.00% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/05/26

• Fundamental Ratios P/E Current FY Estimate: 11.82 Trailing 12 Months: 12.37 PEG Ratio: 1.18 Price Ratios Price/Book: 3.31 Price/Cash Flow: 7.28 Price / Sales: 1.35 EPS Growth vs. Year Ago Period: 87.50% vs. Previous Quarter: -37.50% Sales Growth vs. Year Ago Period: 6.63% vs. Previous Quarter: -16.35% ROE 03/31/26 - 29.97 12/31/25 - 28.88 09/30/25 - 26.38 ROA 03/31/26 - 9.52 12/31/25 - 8.53 09/30/25 - 7.27 Current Ratio 03/31/26 - 1.69 12/31/25 - 1.70 09/30/25 - 1.74 Quick Ratio 03/31/26 - 1.13 12/31/25 - 1.19 09/30/25 - 1.14 Operating Margin 03/31/26 - 11.33 12/31/25 - 10.45 09/30/25 - 9.12 Net Margin 03/31/26 - 4.94 12/31/25 - 4.00 09/30/25 - 1.39 Pre-Tax Margin 03/31/26 - 5.84 12/31/25 - 4.53 09/30/25 - 2.04 Book Value 03/31/26 - 2.80 12/31/25 - 2.76 09/30/25 - 2.50 Inventory Turnover 03/31/26 - 2.02 12/31/25 - 1.95 09/30/25 - 1.92 Debt-to-Equity 03/31/26 - 1.08 12/31/25 - 1.22 09/30/25 - 1.50 Debt-to-Capital 03/31/26 - 51.96 12/31/25 - 54.98 09/30/25 - 60.03

Powered by Zacks Investment Research ©